{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "7698835",
  "DateCompleted": {
    "Year": "1995",
    "Month": "04",
    "Day": "28"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "08",
    "Day": "30"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0300-8126",
      "JournalIssue": {
        "Volume": "22",
        "Issue": "6",
        "PubDate": {
          "Year": "1994",
          "Season": "Nov-Dec"
        }
      },
      "Title": "Infection",
      "ISOAbbreviation": "Infection"
    },
    "ArticleTitle": "Modern topical glucocorticoids and anti-infectives for superinfected atopic eczema: do prednicarbate and didecyldimethylammoniumchloride form a rational combination?",
    "Pagination": {
      "StartPage": "390",
      "EndPage": "394",
      "MedlinePgn": "390-4"
    },
    "Abstract": {
      "AbstractText": [
        "The addition of an anti-infective to a topical glucocorticoid preparation for superinfected atopic eczema is still controversial. To address this question in the context of the topical glucocorticoids of the non-halogenated double-ester type 0.25% prednicarbate cream was compared to the identical preparation incorporating the same amount of the disinfectant didecyldimethylammoniumchloride in patients suffering from atopic eczema carrying Staphylococcus aureus at a density of more than 10(6) colony-forming units per cm2. One of the preparations was used twice daily over 5 days according to a random plan in a blind fashion. Thereafter treatment was based on either prednicarbate cream or the corresponding vehicle according to clinical needs. Clinical and microbiological evaluation were scheduled for days 0, 6 and 34. Various clinical parameters were addressed individually as well as over all improvement using scores. A total of 143 patients was recruited. The patients of both groups improved rapidly with respect to clinical and microbiological findings. Essentially, there was no difference between the groups. Hence, the addition of an anti-infective to a topical prednicarbate preparation is not to be generally recommended."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Dermatologische Klinik und Poliklinik, Ludwig-Maximilians-Universit\u00e4t, M\u00fcnchen, Germany."
          }
        ],
        "LastName": "Korting",
        "ForeName": "H C",
        "Initials": "HC"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Zienicke",
        "ForeName": "H",
        "Initials": "H"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Braun-Falco",
        "ForeName": "O",
        "Initials": "O"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Bork",
        "ForeName": "K",
        "Initials": "K"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Milbradt",
        "ForeName": "R",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Nolting",
        "ForeName": "S",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Sch\u00f6pf",
        "ForeName": "E",
        "Initials": "E"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Tronnier",
        "ForeName": "H",
        "Initials": "H"
      }
    ],
    "PublicationTypeList": [
      "Clinical Trial",
      "Comparative Study",
      "Journal Article",
      "Multicenter Study",
      "Randomized Controlled Trial",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Germany",
    "MedlineTA": "Infection",
    "NlmUniqueID": "0365307",
    "ISSNLinking": "0300-8126"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Inflammatory Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Drug Combinations"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Glucocorticoids"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Quaternary Ammonium Compounds"
    },
    {
      "RegistryNumber": "9PHQ9Y1OLM",
      "NameOfSubstance": "Prednisolone"
    },
    {
      "RegistryNumber": "V901LV1K7D",
      "NameOfSubstance": "prednicarbate"
    },
    {
      "RegistryNumber": "Z7F472XQPA",
      "NameOfSubstance": "didecyldimethylammonium"
    }
  ],
  "CommentsCorrectionsList": [
    {
      "RefSource": "Infection 1995 Jan-Feb;23(1):67"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Administration, Topical"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Adolescent"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Anti-Inflammatory Agents"
    },
    {
      "QualifierName": [
        "complications",
        "drug therapy"
      ],
      "DescriptorName": "Dermatitis, Atopic"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Double-Blind Method"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Combinations"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Glucocorticoids"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [
        "analogs & derivatives",
        "therapeutic use"
      ],
      "DescriptorName": "Prednisolone"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Quaternary Ammonium Compounds"
    },
    {
      "QualifierName": [
        "complications",
        "drug therapy"
      ],
      "DescriptorName": "Staphylococcal Skin Infections"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Staphylococcus aureus"
    },
    {
      "QualifierName": [
        "complications",
        "drug therapy"
      ],
      "DescriptorName": "Superinfection"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Treatment Outcome"
    }
  ],
  "NumberOfReferences": "22"
}